Prevention of colitis-associated colorectal cancer with 8-hydroxydeoxyguanosine

Cancer Prevention Research

Volumn 4, Issue 9, 2011, Pages 1507-1521

  Ock, Chan Young ^a   Kim, Eun Hee ^a   Hong, Hua ^a   Hong, Kyung Sook ^a   Han, Young Min ^a   Choi, Ki Seok ^a   Hahm, Ki Baik ^a,c   Chung, Myung Hee ^b  

^a Gachon University   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Inha University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BETA CATENIN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; MALONALDEHYDE; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN SYNTHASE; RAC1 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CANCER PREVENTION; CARCINOGENESIS; COLITIS; COLITIS ASSOCIATED CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DIETARY INTAKE; ENZYME INACTIVATION; EXPERIMENTAL MODEL; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; AZOXYMETHANE; COLITIS; COLORECTAL NEOPLASMS; DEOXYGUANOSINE; DEXTRANS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; INFLAMMATION; INTERLEUKIN-10; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOPLASMS; STAT3 TRANSCRIPTION FACTOR; SULFATES;

EID: 80052591755     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-11-0161     Document Type: Article

References (50)

1. Langholz E., Munkholm P., Davidsen M., Binder V. Course of ulcerative colitis: Analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11. (Pubitemid 24195339)
2. Rosenstock E., Farmer R.G., Petras R., Sivak M.V. Jr, Rankin G.B., Sullivan B.H. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-1346 (Pubitemid 16228058)
3. Feagins L.A., Souza R.F., Spechler S.J. Carcinogenesis in IBD: Potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 2009;6:297-305.
4. Kim Y.J., Hong K.S., Chung J.W., Kim J.H., Hahm K.B. Prevention of colitisassociated carcinogenesis with infliximab. Cancer Prev Res 2010;3: 1314-1333
5. Imperiale T.F. Aspirin and the prevention of colorectal cancer. N Engl J Med 2003;348:879-880 (Pubitemid 36297994)
6. Wang D., Dubois R.N., Richmond A. The role of chemokines in intestinal inflammation and cancer. Curr Opin Pharmacol 2009;9:688-696
7. Zimmerman N.P., Vongsa R.A., Wendt M.K., Dwinell M.B. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm Bowel Dis 2008;14:1000-1011
8. Greenhough A., Smartt H.J., Moore A.E., Roberts H.R., Williams A.C., Paraskeva C., et al. The COX-2/PGE2 pathway: Key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis 2009;30:377-386
9. Myung S.J., Rerko R.M., Yan M., Platzer P., Guda K., Dotson A., et al. 15- Hydroxyprostaglandin dehydrogenase is an in vivo suppressor of colon tumorigenesis. Proc Natl Acad Sci U S A 2006;103: 12098-12102 (Pubitemid 44215817)
10. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature 2006;441:431-436 (Pubitemid 44050137)
11. Schreiber S., Nikolaus S., Hampe J. Activation of nuclear factor kappa B inflammatory bowel disease. Gut 1998;42:477-484 (Pubitemid 28186562)
12. Xie T-X, Wei D., Liu M., Gao A.C., Ali-Osman F., Sawaya R., et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis. Oncogene 2004;23:3550-3560 (Pubitemid 38658421)
13. Zucker S., Vacirca J. Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 2004;23:101-117 (Pubitemid 38221598)
14. Inoue J., Gohda J., Akiyama T., Semba K. NF-kappaB activation in development and progression of cancer. Cancer Sci 2007;98: 268-274 (Pubitemid 46195594)
15. Klampfer L. Cytokines, inflammation and colon cancer. Curr Cancer Drug Targets 2011;11:451-464
16. Hovanes K., Li T.W., Munguia J.E., Truong T., Milovanovic T., Lawrence Marsh J., et al. Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer. Nat Genet 2001;28:53-57 (Pubitemid 32405817)
17. Hata K., Yamada Y., Kuno T., Hirose Y., Hara A., Qiang S.H., et al. Tumor formation is correlated with expression of beta-catenin-accumulatedcrypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci 2004;95:316-320 (Pubitemid 38519471)
18. Knudson A.G. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001;1:157-162 (Pubitemid 33741891)
19. Ock C.Y., Hong K.S., Choi K.S., Chung M.H., Kim Y., Kim J.H., et al. A novel approach for stress-induced gastritis based on paradoxical antioxidative and anti-inflammatory action of exogenous 8-hydroxydeoxyguanosine. Biochem Pharmacol 2011;81:111-122
20. Choi S., Choi H-H, Lee S-H, Ko S.H., You H.J., Ye S.K., et al. Antiinflammatory effects of 8-hydroxy-20-deoxyguanosine on lipopolysaccharide- induced inflammation via Rac suppression in Balb/c mice. Free Radic Biol Med 2007;43:1594-1603 (Pubitemid 350122983)
21. Kim H.S., Ye S-K, Cho I.H., Jung J.E., Kim D.H., Choi S., et al. 8-hydroxydeoxyguanosine suppresses NO production and COX-2 activity via Rac1/STATs signaling in LPS-induced brain microglia. Free Radic Biol Med 2006;41:1392-1403 (Pubitemid 44466722)
22. Ro J.Y., Kim D.Y., Lee S-H, Park J.W., Chung M-H. Effects of 7,8-dihydro- 8-oxo-deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of Rac. Br J Pharmacol 2009;158:1743-1752
23. Simon A.R., Vikis H.G., Stewart S., Fanburg B.L., Cochran B.H., Guan K.L. Regulation of STAT3 by direct binding to the Rac1 GTPase. Science 2000;290:144-147
24. Tanaka T., Kohno H., Suzuki R., Yamada Y., Sugie S., Mori H. A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate. Cancer Sci 2003; 94:965-973 (Pubitemid 37508979)
25. Kim Y.J., Lee J.S., Hong K.S., Chung J.W., Kim J.H., Hahm K.B. Novel application of proton pump inhibitor for the prevention of colitisinduced colorectal carcinogenesis beyond acid suppression. Cancer Prev Res 2010;3:963-974
26. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin- 10-deficient mice develop chronic enterocolitis. Cell 1993;75: 263-274 (Pubitemid 23320290)
27. Kojima M., Morisaki T., Izuhara K., Uchiyama A., Matsunari Y., Katano M., et al. Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation. Oncogene 2000;19:1225-1231 (Pubitemid 30157553)
28. Yoon S-H, Hyun J-W, Choi J., et al. In vitro evidence for the recognition of 8-oxoGTP by Ras, a small GTP-binding protein. Biochem Biophys Res Commun 2005;327:342-348 (Pubitemid 40051390)
29. Mitsuyama K., Sata M., Rose-John S. Interleukin-6 trans-signaling in inflammatory bowel disease. Cytokine Growth Factor Rev 2006;17: 451-461 (Pubitemid 44793118)
30. Mudter J., Neurath M.F. Il-6 signaling in inflammatory bowel disease: Pathophysiological role and clinical relevance. Inflamm Bowel Dis 2007;13:1016-1023 (Pubitemid 47309974)
31. Manea A., Tanase I., Raicu M., Simionescu M. JAK/STAT signaling pathway regulates Nox1 and Nox4-based NADPH oxidase in human aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 2010;30:105-112
32. Kuwano Y., Kawahara T., Yamamoto H., Teshima-Kondo S., Tominaga K., Masuda K., et al. Interferon-gamma activates transcription of NADPH oxidase 1 gene and upregulates production of superoxide anion by human large intestinal epithelial cells. Am J Physiol Cell Physiol 2006;290:C433-C443
33. Loft S., Vistisen K., Ewertz M., Tjønneland A., Overvad K., Poulsen H.E. Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: Influence of smoking, gender and body mass index. Carcinogenesis 1992;13:2241-2247 (Pubitemid 23022963)
34. Wu L.L., Chiou C.C., Chang P.Y., Wu J.T. Urinary 8-OHdG: A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9. (Pubitemid 37542453)
35. Cooke M.S., Evans M.D., Dove R., Rozalski R., Gackowski D., Siomek A., et al. DNA repair is responsible for the presence of oxidatively damaged DNA lesions in urine. Mutat Res 2005;574:58-66. (Pubitemid 40725968)
36. Shibutani S., Takeshita M., Grollman A.P. Insertion of specific bases during DNA synthesis past the oxidation-damaged base 8-oxodG. Nature 1991;349:431-434 (Pubitemid 21926107)
37. Moriya M. Single-stranded shuttle phagemid for mutagenesis studies in mammalian cells: 8-oxoguanine in DNA induces targeted G.C->T.A transversions in simian kidney cells. Proc Natl Acad Sci U S A 1993;90:1122-1126 (Pubitemid 23053963)
38. Kim J-E, Chung M-H. 8-Oxo-7,8-dihydro-20-deoxyguanosine is not salvaged for DNA synthesis in human leukemic U937 cells. Free Radic Res 2006;40:461-466
39. Kim J-E, Hyun J-W, Hayakawa H., Choi S., Choi J., Chung M-H. Exogenous 8-oxo-dG is not utilized for nucleotide synthesis but enhances the accumulation of 8-oxo-Gua in DNA through error-prone DNA synthesis. Mutat Res 2006;596:128-136
40. Burridge K., Wennerberg K. Rho and Rac take center stage. Cell 2004;116:167-179 (Pubitemid 38167310)
41. Embade N., Valeron P.F., Aznar S., Lopez-Collazo E., Lacal J.C. Apoptosis induced by Rac GTPase correlates with induction of FasL and ceramides production. Mol Biol Cell 2000;11:4347-4358
42. Bedard K., Krause K-H. The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology. Physiol Rev 2007;87: 245-313. (Pubitemid 46209993)
43. Wang R., Dashwood W-M, Nian H., Löohr C.V., Fischer K.A., Tsuchiya N., et al. NADPH oxidase overexpression in human colon cancers and rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5- b]pyridine (PhIP). Int J Cancer 2011;128:2581-2590
44. Kohno H., Suzuki R., Sugie S., Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer. 2005;5:46.
45. Arber N. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: Point. Cancer Epidemiol Biomarkers Prev 2008;17:1852-1857
46. Jankowski J., Hunt R. Cyclooxygenase-2 inhibitors in colorectal cancer prevention: Counterpoint. Cancer Epidemiol Biomarkers Prev 2008;17:1858-1861
47. Mueller L., Von Seggern L., Schumacher J., Goumas F., Wilms C., Braun F., et al. TNF-alpha similarly induces IL-6 and MCP-1 in fibroblasts from colorectal liver metastases and normal liver fibroblasts. Biochem Biophys Res Commun 2010;397:586-591
48. Baugh M.D., Perry M.J., Hollander A.P., Davies D.R., Cross S.S., Lobo A.J., et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814-822 (Pubitemid 29468223)
49. Medina C., Radomski M.W. Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 2006;318:933-938 (Pubitemid 44268297)
50. Humphries A., Wright N.A. Colonic crypt organization and tumorigenesis. Nat Rev Cancer 2008;8:415-424 (Pubitemid 351744961)